Particle.news

Bundibugyo Ebola in DR Congo Nears 600 Cases as International Measures and Local Unrest Escalate

The rare Bundibugyo strain has no approved vaccine or targeted therapy, increasing spread risk and triggering urgent international coordination.

Overview

  • Government figures show about 598 confirmed infections and at least 115 deaths in eastern DR Congo, numbers that rose sharply in early June and keep the outbreak active.
  • The World Health Organization has declared a public‑health emergency and, with Africa CDC, launched a $518 million continental response plan to boost surveillance, labs, protective gear and care.
  • Violent conflict, attacks on health teams and low contact tracing—reported between roughly 56% and 64% versus the WHO target of 90%—are blocking case finding and isolation in Ituri, North Kivu and South Kivu.
  • The United States has imposed CDC travel restrictions and urged European entry limits while preparing a quarantine facility in Kenya, a move that has provoked repeated protests there and at least one confirmed death.
  • High‑resource hospitals have treated evacuated patients with experimental antibody therapy (MBP134) and remdesivir with apparent success, but those therapies require cold chains, IV care and are not yet deployable at scale in the outbreak zone.